The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMTE.L Regulatory News (AMTE)

  • There is currently no data for AMTE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Financing and corporate update

28 Jun 2023 10:21

RNS Number : 2364E
AMTE Power PLC
28 June 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) NO 596/2014 WHICH FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

For immediate release

 

28 June 2023

 

AMTE Power Plc

Financing and corporate update

 

AMTE Power Plc (AIM: AMTE) ("AMTE Power" or the "Company"), a leading developer and manufacturer of lithium-ion and sodium-ion battery cells for specialist markets, today announces a further update to its financing position.

Further to its announcement on 15 June 2023 (the "Announcement"), the Company continues to be in discussions with potential investors concerning raising further finance.

However, given the passage of time since the Announcement, it is now considering all credible options, including a sale of the Company's business, in relation to which FRP Corporate Finance is advising, in order to act in the best interest of all stakeholders in the Company. At this stage, the Company is not actively pursuing a sale of the Company itself.

Whilst active discussions are ongoing with various parties, there can be no certainty of the outcome of these discussions.

Accordingly, in light of AMTE Power's reducing cash position, should the Company be unable to secure additional funding within no less than the next three weeks, the prospects for recovery of value, if any, by shareholders would be uncertain.

Further announcements will be made as and when appropriate.

The person responsible for arranging the release of this announcement on behalf of the Company is Anita Breslin, Chief Financial Officer of the Company.

Enquiries

AMTE Power plc

+44 (0)1847 867 200

Alan Hollis (Chief Executive Officer)

Anita Breslin (Chief Financial Officer)

WH Ireland (NOMAD and Joint Broker)

+44 (0)207 220 1666

Chris Fielding / James Bavister (Corporate Finance)

Fraser Marshall (Corporate Broking)

FRP Corporate Finance (Financial Adviser)

+44 (0)20 3005 4000

Chris Adlam/Joanne Price

ProjectCellProcess@frpadvisory.com

 

 

Panmure Gordon (UK) Limited (Joint Broker)

+44 (0)207 886 2500

John Prior / James Sinclair-Ford (Corporate Finance)

Hugh Rich (Corporate Broking)

 

Camarco (Financial PR)

 

 

 

+44 (0)203 757 4992 / 4981

Ginny Pulbrook / Rosie Driscoll

 

About AMTE Power

AMTE Power was founded in 2013 and is a leading UK developer and manufacturer of lithium-ion and sodium-ion battery cells for specialist markets. In March 2021, the Company was admitted to trading on the AIM market of the London Stock Exchange. The Company is focused on launching a series of next generation battery cells based on new chemistries and cell structures that are designed to solve key problems in power delivery, energy performance, and safety. These new products are targeted at a range of specialist markets including the electric vehicle industry and energy storage sector.

AMTE Power's purpose-built cell manufacturing facility in Thurso, Scotland has the second largest cell manufacturing capacity in the UK and the Company also has a product development team based in Oxford. AMTE's proposed gigafactory in Dundee, Scotland is expected to be capable of producing over 8 million battery cells per annum enabling the Company to rapidly scale up cell production.

For further information visit the Company's website: www.amtepower.com

Important notice

This announcement is for information purposes only and does not constitute or form part of any offer to issue or sell, or the solicitation of an offer to acquire, purchase or subscribe for, any securities in any jurisdiction and should not be relied upon in connection with any decision to subscribe for or acquire ordinary shares in the capital of the Company. In particular, this announcement does not constitute or form part of any offer to issue or sell, or the solicitation of an offer to acquire, purchase or subscribe for, any securities in the United States.

This announcement has been issued by, and is the sole responsibility of, the Company. No person has been authorised to give any information or to make any representations other than those contained in this announcement and, if given or made, such information or representations must not be relied on as having been authorised by the Company.

No statement in this announcement is intended to be a profit forecast or profit estimate and no statement in this announcement should be interpreted to mean that earnings per share of the Company for the current or future financial years would necessarily match or exceed the historical published earnings per share of the Company.

This announcement may include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "plans", "projects", "anticipates", "expects", "intends", "may", "will", "would" or "should" or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include matters that are not historical facts. They appear in a number of places throughout this announcement and include statements regarding the directors of the current Company's intentions, beliefs or expectations concerning, among other things, the Company's results of operations, financial condition, liquidity, prospects, growth, strategies, and the Company's markets. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Actual results and developments could differ materially from those expressed or implied by the forward-looking statements. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements in this announcement are based on certain factors and assumptions, including the directors of the Company's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Company's operations, results of operations, growth strategy and liquidity. Whilst the directors of the Company consider these assumptions to be reasonable based upon information currently available, they may prove to be incorrect. Save as required by applicable law, the AIM Rules or the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the Company undertakes no obligation to release publicly the results of any revisions to any forward-looking statements in this announcement that may occur due to any change in the directors of the Company's expectations or to reflect events or circumstances after the date of this announcement.

Neither the content of the Company's website nor any website accessible by hyperlinks to the Company's website is incorporated in, or forms part of, this announcement.

Certain figures contained in this announcement, including financial information, have been subject to rounding adjustments. Accordingly, in certain instances, the sum or percentage change of the numbers contained in this announcement may not conform exactly with the total figure given.

All references to time in this announcement are to London time, unless otherwise stated.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDKVLBLXQLFBBK
Date   Source Headline
20th Feb 20247:00 amRNSCancellation - AMTE Power plc
2nd Feb 20247:00 amRNSSale of business and assets
19th Jan 20241:22 pmRNSAppointment of administrators
8th Jan 202411:19 amRNSUpdate on intention to appoint administrators
28th Dec 202311:18 amRNSResult of AGM
19th Dec 20233:03 pmRNSIntention to Appoint Administrators
19th Dec 20233:02 pmRNSSuspension - AMTE Power Plc
4th Dec 20233:38 pmRNSPosting of subscription general meeting circular
4th Dec 202311:12 amRNSResult of General Meeting
16th Nov 20231:31 pmRNSProposed subscription, placing and CLF
15th Nov 20232:00 pmRNSFinancing Update
10th Nov 20234:32 pmRNSFinancing Update
2nd Oct 20234:12 pmRNSResult of Retail Offer
27th Sep 20232:00 pmRNSRetail Offer
26th Sep 20231:23 pmRNSN04/23 - AMTE Power plc - Restoration of trading
25th Sep 202311:35 amRNSResult of General Meeting, TVR and Retail Offer
13th Sep 20237:26 amRNSN03/23 - AMTE Power plc - Suspension of trading
11th Sep 202312:24 pmRNSPosting of Circular
8th Sep 20237:00 amRNSResult of placing and announcement of Retail Offer
2nd Aug 20237:00 amRNSDirectorate Change
25th Jul 20233:44 pmRNSLoan facility to facilitate proposed equity raise
20th Jul 20237:00 amRNSFinancing update
29th Jun 20234:03 pmRNSFaraday Battery Challenge
29th Jun 20233:37 pmRNSUN Certification of Ultra High Power Cells
29th Jun 202311:22 amRNSFaraday Battery Challenge
29th Jun 202311:21 amRNSUN Certification of Ultra High Power Cells
28th Jun 202310:21 amRNSFinancing and corporate update
15th Jun 20237:00 amRNSFinancing Update
4th May 20237:00 amRNSUN38.3 Certification of Ultra Safe Cells
28th Apr 20233:43 pmRNSConversion of Convertible Loan Notes and TVR
26th Apr 20237:00 amRNSMOU with CalPac Resources
25th Apr 20237:00 amRNSDrawdown from convertible bond facility
20th Apr 20237:00 amRNSConversion of Convertible Loan Notes and TVR
31st Mar 202312:51 pmRNSHighlands and Islands Enterprise loan
13th Mar 20237:00 amRNSConversion of Convertible Loan Notes and TVR
8th Mar 20237:00 amRNSHalf Year Results
7th Mar 20235:21 pmRNSAmendment to the convertible bond facility
3rd Mar 20237:00 amRNSDelivery of Ultra Prime Cells
25th Jan 20237:00 amRNSNotice of Interim Results
29th Dec 20222:26 pmRNSResults of AGM
1st Dec 20227:00 amRNSFinal Results
30th Nov 20224:35 pmRNSNotice of Final Results
22nd Nov 20227:00 amRNSConversion of Convertible Loan Notes
21st Nov 20221:23 pmRNSStandard form for notification of major holdings
17th Nov 20227:00 amRNSBoard Appointment
4th Nov 202212:09 pmRNSAMTE Power signs convertible bond facility
3rd Nov 20221:02 pmRNSResult of General Meeting
31st Oct 20227:00 amRNSRe Directorate
31st Oct 20227:00 amRNSBlock Listing Six Monthly Return
17th Oct 20227:00 amRNSProposed £5 million convertible bond facility

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.